Antiangiogenic gene therapy.
作者信息
Folkman J
机构信息
Department of Surgery, Children's Hospital, Boston, MA 02115, USA.
出版信息
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9064-6. doi: 10.1073/pnas.95.16.9064.
Abstract
摘要
相似文献
1
Antiangiogenic gene therapy.
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9064-6. doi: 10.1073/pnas.95.16.9064.
2
Future prospects and challenges of antiangiogenic cancer gene therapy.
Hum Gene Ther. 2010 Apr;21(4):381-96. doi: 10.1089/hum.2010.017.
3
Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
Hum Gene Ther. 2000 Sep 20;11(14):1983-96. doi: 10.1089/10430340050143417.
4
Antiangiogenic Eye Gene Therapy.
Hum Gene Ther. 2015 Aug;26(8):525-37. doi: 10.1089/hum.2015.064.
5
Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma.
Int J Cancer. 2012 Nov 15;131(10):2394-401. doi: 10.1002/ijc.27495. Epub 2012 Mar 27.
6
Researchers target tumour blood vessels with antiangiogenic gene therapy.
Lancet. 2002 Jun 29;359(9325):2256. doi: 10.1016/S0140-6736(02)09319-4.
7
Antiangiogenic gene therapy in inhibition of metastasis.
Acta Biochim Pol. 2002;49(2):313-21.
8
Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography.
Gene Ther. 1999 Apr;6(4):606-15. doi: 10.1038/sj.gt.3300841.
9
Antiangiogenic therapy enhances the efficacy of transcatheter arterial embolization for hepatocellular carcinomas.
Int J Cancer. 2007 Jul 15;121(2):416-24. doi: 10.1002/ijc.22655.
10
Progress in antiangiogenic gene therapy of cancer.
Cancer. 2000 Sep 15;89(6):1181-94.
引用本文的文献
1
Anticancer Effect of Heparin-Taurocholate Conjugate on Orthotopically Induced Exocrine and Endocrine Pancreatic Cancer.
Cancers (Basel). 2021 Nov 18;13(22):5775. doi: 10.3390/cancers13225775.
2
Circular dumbbell miR-34a-3p and -5p suppresses pancreatic tumor cell-induced angiogenesis and activates macrophages.
Oncol Lett. 2021 Jan;21(1):75. doi: 10.3892/ol.2020.12336. Epub 2020 Nov 25.
3
Antiangiogenic Gene Therapy in Cancer.
Curr Genomics. 2000;1(2):117-133. doi: 10.2174/1389202003351535.
4
Effects of lentivirus-mediated endostatin on endothelial progenitor cells.
Oncotarget. 2017 Oct 10;8(55):94431-94439. doi: 10.18632/oncotarget.21770. eCollection 2017 Nov 7.
5
Mitochondrial Redox Signaling and Tumor Progression.
Cancers (Basel). 2016 Mar 25;8(4):40. doi: 10.3390/cancers8040040.
6
Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.
Oncotarget. 2014 Jul 30;5(14):5403-15. doi: 10.18632/oncotarget.2114.
7
Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System.
Mol Cancer. 2011 Feb 10;10(1):14. doi: 10.1186/1476-4598-10-14.
8
Anti-tumor effect of lentivirus-mediated gene transfer of alphastatin on human glioma.
Cancer Sci. 2011 May;102(5):1038-44. doi: 10.1111/j.1349-7006.2011.01879.x. Epub 2011 Feb 24.
9
A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326.
Cancer. 2010 Dec 15;116(24):5686-93. doi: 10.1002/cncr.25448.
10
Inhibition effect of pcDNA-tum-5 on the growth of S180 tumor.
Cytotechnology. 2008 Feb;56(2):97-104. doi: 10.1007/s10616-007-9117-9. Epub 2007 Dec 30.
本文引用的文献
1
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8829-34. doi: 10.1073/pnas.95.15.8829.
2
Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate.
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8795-800. doi: 10.1073/pnas.95.15.8795.
3
Gene therapy for therapeutic myocardial angiogenesis: a promising synthesis of two emerging technologies.
Nat Med. 1998 Jun;4(6):739-42. doi: 10.1038/nm0698-739.
4
Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest.
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6367-72. doi: 10.1073/pnas.95.11.6367.
5
A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6343-8. doi: 10.1073/pnas.95.11.6343.
6
Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases.
J Clin Invest. 1998 Mar 1;101(5):1055-63. doi: 10.1172/JCI1558.
7
Gene therapy strategies for tumor antiangiogenesis.
J Natl Cancer Inst. 1998 Feb 18;90(4):273-86. doi: 10.1093/jnci/90.4.273.
8
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.
Nature. 1997 Nov 27;390(6658):404-7. doi: 10.1038/37126.
9
Why are we doing so much cancer gene therapy? Disentangling the scientific basis from the origins of gene therapy.
Gene Ther. 1997 Aug;4(8):755-6. doi: 10.1038/sj.gt.3300494.
10
Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.
J Clin Invest. 1997 Oct 15;100(8):2072-8. doi: 10.1172/JCI119740.
Zotero 插件